After the oligosaccharide core is transferred to the protein, additional modifications take place through the action of glycosyltransferases as well as through the removal of certain glycosyl residues. These modifications occur as the protein migrates through the Golgi apparatus to the cell surface.
back to the top
Lysosomal Targeting of Enzymes
Enzymes that are destined for the lysosomes (lysosomal enzymes) are directed there by a specific carbohydrate modification. During transit through the Golgi apparatus a residue of a-N-acetylglucosamine-1-phosphate (GlcNAc-1-P) is added to carbon 6 of one or more specific mannose residues that have been incorporated into these enzymes. The GlcNAc is activated by coupling to UDP and is transferred by UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase (GlcNAc phosphotransferase), yielding a phosphodiester intermediate: GlcNAc-1-P-6-Man-protein. A second reaction (catalyzed by GlcNAc 1-phosphodiester-N-acetylglucosaminidase) removes the GlcNAc, leaving mannose residues phosphorylated in the 6 position: Man-6-P-protein. A specific Man-6-P receptor is present in the membranes of the Golgi apparatus. Binding of Man-6-P to this receptor targets proteins to the lysosomes.
Two distinct Man-6-P receptors have been identified. Both are integral membrane proteins. One receptor is large with a molecular weight of approximately 275,000 Daltons. The other receptor is smaller with a molecular weight of approximately 46,000 Daltons. Structural similarities between these two receptors indicates they are derived from a single ancestral gene with the larger receptor arising through multiple gene duplications. The large receptor binds 2 mol of Man-6-P and the smaller 1 mol of Man-6-P per subunit. The larger receptor does not require divalent cations for ligand binding and is termed the cation-independent Man-6-P receptor, CI-MPR. In some species (however, not humans) the smaller receptor does require cation for ligand binding and is termed the CD-MPR.
The human CI-MPR also binds the nonglycosylated polypeptide hormone insulin-like growth factor II (IGF-II) and has thus been termed the Man-6-P/IGF-II receptor. The IGF-II and Man-6-P binding sites on the receptor are distinct from each other. Evidence indicates that both receptors function to target newly synthesized lysosomal enzymes to the lysosomes.
back to the top
Clinical Significances of Glycoproteins
Glycoproteins on cell surfaces are important for communication between cells, for maintaining cell structure and for self-recognition by the immune system. The alteration of cell-surface glycoproteins can, therefore, produce profound physiological effects, of which several are listed below.
- 1. The ABO blood group antigens
are the carbohydrate moieties of glycolipids on the surface of cells as well as the carbohydrate portion of serum glycoproteins. When present on the surface of cells the ABO carbohydrates are linked to sphingolipid and are therefore of the glycosphingolipid class. When the ABO carbohydrates are associated with protein in the form of glycoproteins they are found in the serum and are referred to as the secreted forms. Some individuals produce the glycoprotein forms of the ABO antigens while others do not. This property distinguishes secretors from non-secretors, a property that has forensic importance such as in cases of rape.
 |
Structure of the ABO Blood Group Carbohydrates R represents the linkage to protein in the secreted forms, sphingolipid in the cell-surface bound form |
- 2. The truncation of erythrocyte surface glycoproteins leads to cell clumping, as in HEMPAS (congenital dyserythropoietic anemia type II).
- 3. Several viruses, bacteria and parasites have exploited the presence of cell-surface carbohydrates, principally associated with protein (glycoproteins), using them as portals of entry into the cell.
- A. Human immunodeficiency virus (HIV), the causative agent of AIDS
, gains entry into cells of the immune system by attaching to a class of cellular receptors known as the chemokine receptors, most notably CXCR4 and CCR5.
- B. Members of the poxvirus family of viruses gain entry into cells, most frequently migratory leukocytes, by attaching to chemokine receptors including CCR1, CCR5 and CXCR4 (Science [1999] vol. 286 pp. 1968-1971).
- C. Dystroglycan (DG) is a component of the dystrophin-glycoprotein complex. It is a laminin receptor encoded by a single gene and cleaved by postranslational processing into two proteins, peripheral membrane a-DG and transmembrane b-DG. a-DG interacts with laminin-2 in the basal lamina and b-DG binds to dystrophin containing cytoskeletal proteins in muscle and peripheral nerves. DG is involved in agrin- and laminin-induced acetylcholine receptor clustering at neuromuscular junctions, morphogenesis, early development, and the pathogenesis of muscular dystrophies. Recent evidence (Science (1998) vol. 282 pp. 2076-2079 and 2079-2081) demonstrates that a-DG present on Schwann cell membranes is the receptor for Mycobacterium leprae and also serves as the receptor for the arenavirus class of pathogens. Arenaviruses cause hemorrhagic fever in humans. Lymphocytic choriomeningitis virus (LCMV), Lassa fever virus (LFV), Oliveros and Mobala (all members of the arenavirus family) all bind to a-DG. The specificity of this interaction was demonstrated by the resistance to LCMV infection of cells harboring a null mutation in DG.
- D. Rhinoviruses utilize attachment to ICAM-1 (intercellular adhesion molecule-1) to gain entry into cells.
- E. The pathogenic human parvovirus, B19, attaches to the erythrocyte-specific cell-surface globoside identified as erythrocyte P antigen to infect erythrocytes.
- F. The malarial parasite Plasmodium vivax, binds to the erythrocyte chemokine receptor known as the Duffy blood group antigen (also known as the erythrocyte receptor for interleukin-8) to infect erythrocytes.
- G. The MN blood group system is a well-characterized set of erythrocyte surface antigens that represent the variable carbohydrate modifications of the trans-membrane glycoprotein, glycophorin. Glycophorin is the cellular receptor for influenza virus as well as the receptor for erythrocyte invasion by the malarial parasite Plasmodium falciparum.
- H. Helicobacter pylori is the bacterium responsible for chronic active gastritis and gastric and duodenal ulcers; it is also the causative agent for one of the most common forms of cancer in humans, adenocarcinoma. This bacterium attaches to the Lewis blood group antigen on the surfaces of gastric mucous cells.
- I. Rabies virus binds to cells through interactions with neural cell adhesion molecule (N-CAM).
- J. The receptor for fibroblast growth factor (FGF) has been reported to be the portal of entry for human herpes virus Type I. Recent new evidence indicates that the portal of entry for human herpes simplex Type I viruses is 3-O-sulfated heparan sulfate (Cell 99:13-22, 1999).
- K. Human herpesvirus 6 (HHV-6) infection occurs in virtually all persons within the first 2 years of life and persists the entire lifetime. In immunocompromised patients HHV-6 causes opportunistic infections and is the causative agent of exanthema subitum. HHV-6 has been linked to multiple sclerosis and to the progression of AIDS. The cellular receptor for HHV-6 is the cell-surface type-I glycoprotein, CD46 (Cell 99:817-827, 1999).
4. Some glycoproteins are tethered to the membrane by a lipid linkage: the protein is attached to the carbohydrate through phosphatidylethanolamine (PE) linkage, and the carbohydrate is in turn attached to the membrane via linkage to phosphatidylinositol (PI), which anchors the structure within the membrane. The linkage is called a glycosylphosphotidylinositol (GPI) anchor, and proteins that are anchored in this way are termed glypiated proteins. The disease, paroxysmal nocturnal hemoglobinuria, results from the loss of the erythrocyte surface glycoprotein, decay-accelerating factor, (DAF). DAF prevents erythrocyte lysis by complement. When this factor is lost from the erythrocyte surface, abnormal hemolysis occurs, with the end result of hemoglobin accumulation in the urine.
|
| Structure of the GPI linkage |
Other important GPI linked proteins are the enzymes acetylcholinesterase, intestinal and placental alkaline phosphatase and 5'-nucleotidase, the cell adhesion molecule N-CAM (neural cell adhesion molecule) and the T-cell markers Thy-1 and LFA-3 (lymphocyte function associated antigen-3).
- 5. The proper degradation of glycoproteins has medical relevance. Degradation occurs within lysosomes and requires specific lysosomal hydrolases, termed glycosidases. Exoglycosidases remove sugars sequentially from the non-reducing end and exhibit restricted substrate specificities. In contrast, endoglycosidases cleave carbohydrate linkages from within and exhibit broader substrate specificities. Several inherited disorders involving the abnormal storage of glycoprotein degradation products have been identified in humans. These disorders result from defects in the genes encoding specific glycosidases, leading to incomplete degradation and subsequent over-accumulation of partially degraded glycoproteins. As a general class, such disorders are known as lysosomal storage diseases and include the diseases known as mucolipidoses that result from incomplete degradation of the carbohydrate portions of glycolipids.
- 6. Defects in the proper targeting of glycoproteins to the lysosomes can also lead to clinical complications. Deficiencies in the enzyme responsible for the transfer of GlcNAc-1-P to Man residues (GlcNAc phosphotransferase) in lysosomal enzymes leads to the formation of dense inclusion bodies formation in the fibroblasts. Two disorders related to deficiencies in the targeting of lysosomal enzymes are termed I-cell disease (mucolipidosis II) and pseudo-Hurler polydystrophy (mucolipidosis III, also called mucolipidosis-HI). I-cell disease is characterized by severe psychomotor retardation, skeletal abnormalities, coarse facial features, painful restricted joint movement, and early mortality. Pseudo-Hurler polydystrophy is less severe; it progresses more slowly, and afflicted individuals live to adulthood.
Enzyme Defects in Degradation of
Asn-GlcNAc Type Glycoproteins
| Disease | Enzyme Deficiency | Symptoms/Comments |
| aspartylglycosaminuria | aspartylglycosaminidase | progressive mental retardation, delayed speech and motor development, coarse facial features
| b-Mannosidosis | b-Mannosidase | primarily neurological defects, speech impairment |
| a-Mannosidosis | a-Mannosidase | mental retardation, dystosis multiplex, hepatosplenomegaly, hearing loss, delayed speech |
| GM1 Gangliosidosis | b-Galactosidase | also identified as a glycosphingolipid storage disease |
GM2 Gangliosidosis (Sandhoff-Jatzkewitz disease) | b-N-acetylhexosaminidases A and B | also identified as a glycosphingolipid storage disease |
Sialidosis (also identified as Mucolipidosis I) | Neuraminidase (sialidase) | myoclonus, congenital ascites, hepatosplenomegaly, coarse facial features, delayed mental and motor development |
| Fucosidosis | a-Fucosidase | progressive motor and mental deterioration, growth retardation, coarse facial features, recurrent sinus and pulmonary infections |
|
back to the top
OMIM links for additional Defects in Glycoprotein Degradation
Acylation
Many proteins are modified at their N-termini following synthesis. In most cases the initiator methionine is hydrolyzed and an acetyl group is added to the new N-terminal amino acid. Acetyl-CoA is the acetyl donor for these reactions. Some proteins have the 14 carbon myristoyl group added to their N-termini. The donor for this modification is myristoyl-CoA. This latter modification allows association of the modified protein with membranes. The catalytic subunit of cyclicAMP-dependent protein kinase (PKA) is myristoylated.
back to the top
Methylation
Post-translational methylation occurs at lysine residues in some proteins such as calmodulin and cytochrome c. The activated methyl donor is S-adenosylmethionine.
back to the top
Phosphorylation
Post-translational phosphorylation is one of the most common protein modifications that occurs in animal cells. The vast majority of phosphorylations occur as a mechanism to regulate the biological activity of a protein and as such are transient. In other words a phosphate (or more than one in many cases) is added and later removed.
Physiologically relevant examples are the phosphorylations that occur in glycogen synthase and glycogen phosphorylase in hepatocytes in response to glucagon release from the pancreas. Phosphorylation of synthase inhibits its activity, whereas, the activity of phosphorylase is increased. These two events lead to increased hepatic glucose delivery to the blood.
The enzymes that phosphorylate proteins are termed kinases and those that remove phosphates are termed phosphatases. Protein kinases catalyze reactions of the following type:
ATP + protein <----> phosphoprotein + ADP
In animal cells serine, threonine and tyrosine are the amino acids subject to phosphorylation. The largest group of kinases are those that phsophorylate either serines or threonines and as such are termed serine/threonine kinases. The ratio of phosphorylation of the three different amino acids is approximately 1000/100/1 for serine/threonine/tyrosine.
Although the level of tyrosine phosphorylation is minor, the importance of phosphorylation of this amino acid is profound. As an example, the activity of numerous growth factor receptors is controlled by tyrosine phosphorylation.
back to the top
Sulfation
Sulfate modification of proteins occurs at tyrosine residues such as in fibrinogen and in some secreted proteins (eg gastrin). The universal sulfate donor is 3'-phosphoadenosyl-5'-phosphosulphate (PAPS).
Since sulfate is added permanently it is necessary for the biological activity and not used as a regulatory modification like that of tyrosine phosphorylation.
back to the top
Prenylation
Prenylation refers to the addition of the 15 carbon farnesyl group or the 20 carbon geranylgeranyl group to acceptor proteins, both of which are isoprenoid compounds derived from the cholesterol biosynthetic pathway. The isoprenoid groups are attached to cysteine residues at the carboxy terminus of proteins in a thioether linkage (C-S-C). A common consensus sequence at the C-terminus of prenylated proteins has been identified and is composed of CAAX, where C is cysteine, A is any aliphatic amino acid (except alanine) and X is the C-terminal amino acid. In order for the prenylation reaction to occur the three C-terminal amino acids (AAX) are first removed and the cysteine activated by methylation in a reaction utilizing S-adenosylmethionine as the methyl donor.
Important examples of prenylated proteins include the oncogenic GTP-binding and hydrolyzing protein Ras and the g-subunit of the visual protein transducin, both of which are farnesylated. Numerous GTP-binding and hydrolyzing proteins (termed G-proteins) of signal transduction cascades have g-subunits modified by geranylgeranylation.
back to the top
Vitamin C-Dependent Modifications
Modifications of proteins that depend upon vitamin C as a cofactor include proline and lysine hydroxylations and carboxy terminal amidation. The hydroxylating enzymes are identified as prolyl hydroxylase and lysyl hydroxylase. The donor of the amide for C-terminal amidation is glycine.
The most important hydroxylated proteins are the collagens. Several peptide hormones such as oxytocin and vasopressin have C-terminal amidation.
back to the top
Vitamin K-Dependent Modifications
Vitamin K is a cofactor in the carboxylation of glutamine residues. The result of this type of reaction is a g-carboxyglutamate (called a gla residue).
|
| Structure of a gla residue |
The formation of gla residues within several proteins of the blood clotting cascade is critical for their normal function. The presence of gla residues allows the protein to chelate calcium ions and thereby render an altered conformation and biological activity to the protein. The coumarin-based anticoagulants, warfarin and dicumarol function by inhibiting the carboxylation reaction.
back to the top
Return to THCME Medical Biochemistry Page
Michael W. King, Ph.D / Medical Biochemistry / Terre Haute Center for Medical Education / memwk@thcme.indstate.edu
Last modified: Wednesday, 12-Apr-00 15:34:53